Fig. 4From: Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence ScoresIncidence of individual 21-gene Recurrence Scores from 11 to 25, and comparative utilization of chemotherapy based on the score. Most patients in this range are in the lower half (score 11–18). Chemotherapy use in patients sees a dramatic increase starting at a score of 18, and rises steadily for each point increaseBack to article page